sub-header
Subscribe
Back to Results

The Complex Litigation Surrounding Remicade And Its Biosimilar Challengers

| Agnes Juang, Ph.D.Daniel A. Kamkar
Publication

Partners Agnes Juang, Ph.D., and Daniel A. Kamkar co-authored, "The Complex Litigation Surrounding Remicade And Its Biosimilar Challengers" which was published in Biosimilar Development.

Excerpt: Janssen Biotech Inc. and Celltrion Healthcare are engaged in a series of complex litigations over Janssen’s arthritis biologic medicine Remicade (infliximab) and Celltrion’s biosimilar.

Read the full article here >>

Daniel A. Kamkar - Partner - San Diego
Daniel A. Kamkar
Daniel A. Kamkar's practice focuses on worldwide patent prosecution and portfolio management, patent infringement and validity analyses, freedom to operate...
Agnes Juang - Partner - Orange County
Agnes Juang, Ph.D.
Dr. Agnes Juang provides counsel and advice to innovators seeking to protect their inventions and to grow and monetize their IP assets. Her practice includes...